Company Directory / research

PrivateFor profitresearchSouth Korea
Dx&Vx is an AI-based genome analysis platform that develops microbiome products for infants and young children.
Size
51-100 people: larger than 75% of companies with a size listed
Age
25 years old.
Reach
Website ranked #14,785,373 in the world for traffic, about 37 visits a month.
BiotechnologyHealth CareMedical Device
Funding, as listed
$35B currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Dx&Vx, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Dx&Vx may be growing as it has partnered with IT firm LG CNS to develop a bio-healthcare big data platform, which indicates an expansion of its technological capabilities and potential market reach. This collaboration suggests an investment in the company's infrastructure to support its AI-based genome analysis platform. The focus on developing products for a specialized demographic, such as infants and young children, also implies a strategic approach to capturing a niche market within the biotechnology and healthcare industries.
Summaries written by the source dataset, not by us, and not checked.
research in South Korea.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 13,309 companies in South Korea and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.